Table 1 Clinical and demographic characteristics of study subjects
From: Gut microbiome dynamics and associations with mortality in critically ill patients
Variables | Total patients (N = 52) (Median [IQR] or n (%)) |
|---|---|
Age | 67 [22] |
Sex (Male) | 24 (46%) |
Race (Caucasian) | 49 (94%) |
APACHE II score | 27 [11] |
PF ratio | 156 [103] |
Comorbidities | |
ARDS Sepsis-3 Septic Shock Malignancy Diabetes Immunosuppressed COPD | 26 (50%) 34 (65%) 28 (54%) 13 (25%) 18 (35%) 20 (38%) 7 (13%) |
Diet | |
Not being fed Enteral diet Oral diet | 28 (53.8%) 21 (40.4%) 3 (5.8%) |
Antibiotics | |
Azithromycin Cefepime | 9 (17%) 10 (19%) |
Ceftriaxone Ciprofloxacin Piperacillin-tazobactam Vancomycin | 14 (27%) 12 (23%) 31 (60%) 28 (54%) |
Outcomes | |
Death < 1 year Death < 28 days Death-free days | 38 (73%) 28 (54%) 24 [354] |